US1331311027 - REIT

We assign a fundamental rating of **4** out of 10 to **CPT**. **CPT** was compared to 21 industry peers in the **Residential REITs** industry. There are concerns on the financial health of **CPT** while its profitability can be described as average. **CPT** has a decent growth rate and is not valued too expensively.

In the past year **CPT** had a positive cash flow from operations.

Each year in the past 5 years **CPT** has been profitable.

With an excellent **Return On Invested Capital** value of **3.59%**, **CPT** belongs to the best of the industry, outperforming **90.48%** of the companies in the same industry.

The last **Return On Invested Capital** (**3.59%**) for **CPT** is above the 3 year average (**2.43%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.91% | ||

ROE | 5.51% | ||

ROIC | 3.59% |

ROA(3y)4.17%

ROA(5y)3.65%

ROE(3y)7.97%

ROE(5y)6.92%

ROIC(3y)2.43%

ROIC(5y)2.7%

The **Operating Margin** of **CPT** (**20.85%**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 20.85% | ||

PM (TTM) | 14.05% | ||

GM | 62.44% |

OM growth 3Y-8.95%

OM growth 5Y-6.86%

PM growth 3Y29.13%

PM growth 5Y16.11%

GM growth 3Y0.78%

GM growth 5Y0.84%

Compared to 1 year ago, **CPT** has more shares outstanding

Compared to 1 year ago, **CPT** has an improved debt to assets ratio.

Looking at the **Altman-Z score**, with a value of **1.51**, **CPT** belongs to the top of the industry, outperforming **80.95%** of the companies in the same industry.

A Debt/Equity ratio of **0.75** indicates that **CPT** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.75 | ||

Debt/FCF | 9.88 | ||

Altman-Z | 1.51 |

ROIC/WACC0.49

WACC7.35%

A Quick Ratio of **0.06** indicates that **CPT** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.06 | ||

Quick Ratio | 0.06 |

The **Revenue** has been growing by **9.57%** on average over the past years. This is quite good.

EPS 1Y (TTM)-62.32%

EPS 3Y45.35%

EPS 5Y21.77%

EPS growth Q2Q62.96%

Revenue 1Y (TTM)14.72%

Revenue growth 3Y11.42%

Revenue growth 5Y9.57%

Revenue growth Q2Q4.55%

Based on estimates for the next years, **CPT** will show a small growth in **Revenue**. The Revenue will grow by **6.32%** on average per year.

EPS Next Y-62.61%

EPS Next 2Y-40.85%

EPS Next 3Y-26.18%

EPS Next 5YN/A

Revenue Next Year8.69%

Revenue Next 2Y6.27%

Revenue Next 3Y5.86%

Revenue Next 5Y6.32%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The rest of the industry has a similar **Price/Earnings** ratio as **CPT**.

With a **Price/Forward Earnings** ratio of **46.86**, **CPT** can be considered very expensive at the moment.

61.90% of the companies in the same industry are more expensive than **CPT**, based on the **Price/Forward Earnings** ratio.

When comparing the **Price/Forward Earnings** ratio of **CPT** to the average of the S&P500 Index (**20.08**), we can say **CPT** is valued expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 43.9 | ||

Fwd PE | 46.86 |

Based on the **Enterprise Value to EBITDA** ratio, **CPT** is valued cheaper than 95.24% of the companies in the same industry.

Based on the **Price/Free Cash Flow** ratio, **CPT** is valued cheaper than 80.95% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 26.73 | ||

EV/EBITDA | 13.62 |

The decent profitability rating of **CPT** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)2.02

EPS Next 2Y-40.85%

EPS Next 3Y-26.18%

With a **Yearly Dividend Yield** of **4.52%**, **CPT** is a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **4.56**, **CPT** has a dividend in line with its industry peers.

Compared to an average S&P500 **Dividend Yield** of **2.63**, **CPT** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 4.52% |

The dividend of **CPT** has a limited annual growth rate of **5.78%**.

Dividend Growth(5Y)5.78%

Div Incr Years0

Div Non Decr Years0

DP159.63%

EPS Next 2Y-40.85%

EPS Next 3Y-26.18%

**CAMDEN PROPERTY TRUST**

NYSE:CPT (12/1/2023, 7:04:00 PM)

After market: 93 +0.38 (+0.41%)**92.62**

**+2.36 (+2.61%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryResidential REITs

Earnings (Last)10-26 2023-10-26/amc

Earnings (Next)01-31 2024-01-31/amc

Inst Owners98.36%

Inst Owner Change-2.75%

Ins Owners1.17%

Ins Owner Change-0.34%

Market Cap9.89B

Analysts74.4

Price Target117.73 (27.11%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 4.52% |

Dividend Growth(5Y)5.78%

DP159.63%

Div Incr Years0

Div Non Decr Years0

Ex-Date09-28 2023-09-28 (1)

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)72.66%

Min EPS beat(2)3.42%

Max EPS beat(2)141.9%

EPS beat(4)4

Avg EPS beat(4)47.65%

Min EPS beat(4)3.42%

Max EPS beat(4)141.9%

Revenue beat(2)1

Avg Revenue beat(2)48.06%

Min Revenue beat(2)-1.03%

Max Revenue beat(2)97.15%

Revenue beat(4)1

Avg Revenue beat(4)23.56%

Min Revenue beat(4)-1.11%

Max Revenue beat(4)97.15%

PT rev (1m)-6.61%

PT rev (3m)-8.67%

EPS NQ rev (1m)-10.16%

EPS NQ rev (3m)-5.41%

EPS NY rev (1m)0%

EPS NY rev (3m)32.03%

Revenue NQ rev (1m)-1.44%

Revenue NQ rev (3m)-1.3%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.13%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 43.9 | ||

Fwd PE | 46.86 | ||

P/S | 5.18 | ||

P/FCF | 26.73 | ||

P/OCF | 12.82 | ||

P/B | 2.03 | ||

P/tB | 2.03 | ||

EV/EBITDA | 13.62 |

EPS(TTM)2.11

EY2.28%

EPS(NY)1.98

Fwd EY2.13%

FCF(TTM)3.46

FCFY3.74%

OCF(TTM)7.22

OCFY7.8%

SpS17.87

BVpS45.56

TBVpS45.56

PEG (NY)N/A

PEG (5Y)2.02

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.91% | ||

ROE | 5.51% | ||

ROCE | 4.54% | ||

ROIC | 3.59% | ||

ROICexc | 3.6% | ||

ROICexgc | 3.7% | ||

OM | 20.85% | ||

PM (TTM) | 14.05% | ||

GM | 62.44% | ||

FCFM | 19.38% |

ROA(3y)4.17%

ROA(5y)3.65%

ROE(3y)7.97%

ROE(5y)6.92%

ROIC(3y)2.43%

ROIC(5y)2.7%

ROICexc(3y)2.56%

ROICexc(5y)2.78%

ROICexgc(3y)2.64%

ROICexgc(5y)2.88%

ROCE(3y)3.07%

ROCE(5y)3.42%

ROICexcg growth 3Y-8.59%

ROICexcg growth 5Y-6.77%

ROICexc growth 3Y-8.24%

ROICexc growth 5Y-6.6%

OM growth 3Y-8.95%

OM growth 5Y-6.86%

PM growth 3Y29.13%

PM growth 5Y16.11%

GM growth 3Y0.78%

GM growth 5Y0.84%

F-Score4

Asset Turnover0.21

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.75 | ||

Debt/FCF | 9.88 | ||

Debt/EBITDA | 3.75 | ||

Cap/Depr | 69.52% | ||

Cap/Sales | 21.02% | ||

Interest Coverage | 2.98 | ||

Cash Conversion | 79.09% | ||

Profit Quality | 137.96% | ||

Current Ratio | 0.06 | ||

Quick Ratio | 0.06 | ||

Altman-Z | 1.51 |

F-Score4

WACC7.35%

ROIC/WACC0.49

Cap/Depr(3y)98.71%

Cap/Depr(5y)107.34%

Cap/Sales(3y)36.67%

Cap/Sales(5y)37.45%

Profit Quality(3y)56.24%

Profit Quality(5y)65.9%

Growth

EPS 1Y (TTM)-62.32%

EPS 3Y45.35%

EPS 5Y21.77%

EPS growth Q2Q62.96%

EPS Next Y-62.61%

EPS Next 2Y-40.85%

EPS Next 3Y-26.18%

EPS Next 5YN/A

Revenue 1Y (TTM)14.72%

Revenue growth 3Y11.42%

Revenue growth 5Y9.57%

Revenue growth Q2Q4.55%

Revenue Next Year8.69%

Revenue Next 2Y6.27%

Revenue Next 3Y5.86%

Revenue Next 5Y6.32%

EBIT growth 1Y26.28%

EBIT growth 3Y1.45%

EBIT growth 5Y2.06%

EBIT Next Year255.86%

EBIT Next 3Y56.64%

EBIT Next 5YN/A

FCF growth 1Y185.61%

FCF growth 3Y25.89%

FCF growth 5Y16.84%

OCF growth 1Y42.27%

OCF growth 3Y10.26%

OCF growth 5Y11.37%